Exelon (EXC) Receives a Hold From Scotiabank
Exelon Is Maintained at Overweight by Barclays
Exelon Analyst Ratings
Barclays Maintains Exelon(EXC.US) With Buy Rating, Raises Target Price to $44
Barclays Adjusts Price Target on Exelon to $44 From $41
Guggenheim Adjusts Exelon Price Target to $38 From $39
Exelon Analyst Ratings
Morgan Stanley Maintains Exelon(EXC.US) With Hold Rating, Raises Target Price to $45
Exelon (EXC) Receives a Hold From Morgan Stanley
Morgan Stanley Adjusts Price Target on Exelon to $45 From $42, Maintains Equalweight Rating
Exelon Is Maintained at Neutral by UBS
Exelon Initiated at Buy by Jefferies
Exelon Price Target Announced at $46.00/Share by Jefferies
Exelon Analyst Ratings
Jefferies Upgrades Exelon(EXC.US) to Buy Rating, Raises Target Price to $46
Argus Research Initiates Exelon(EXC.US) With Buy Rating
Argus Research Keeps Their Buy Rating on Exelon (EXC)
Exelon Analyst Ratings
Morgan Stanley Maintains Exelon(EXC.US) With Hold Rating, Raises Target Price to $42
Exelon (EXC) Receives a Hold From Morgan Stanley